Associated Papers
Association of CDKN2A polymorphisms with the severity of cervical neoplasia in a Brazilian population.
Vargas-Torres SL et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, 2014
Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.
Peric B et al.
Bmc Medical Genetics, 2008
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
Pjanova D et al.
Melanoma Research, 2007
Genetic polymorphism in bladder cancer.
Wu X et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2007
High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families.
Hocevar M et al.
Croatian Medical Journal, 2006
The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma.
Huber J et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologica, 2006
Epigenetic and genetic analysis of p16 in dermal fibroblasts from type 1 diabetic patients with nephropathy.
Zeng L et al.
Kidney International, 2003
Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene.
Sakano S et al.
International Journal of Cancer, 2003
Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.
Straume O et al.
The American Journal of Pathology, 2002
A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare.
Kumar R et al.
International Journal of Cancer, 2001
Select a paper to view details